References
- Stein DJ, Costa DLC, Lochner C, et al. Obsessive–compulsive disorder. Nat Rev Dis Prim [Internet]. 2019 Aug 1;5(1):52. https://www.nature.com/articles/s41572-019-0102-3
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. InternetAvailable from:. American Psychiatric Association; 2013. https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
- Mataix-Cols D, Do R-C-M, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry [Internet]. 2005 Feb;162(2):228–238. http://www.ncbi.nlm.nih.gov/pubmed/15677583
- Bloch MH, Landeros-Weisenberger A, Rosario MC, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry [Internet]. 2008 Dec;165(12):1532–1542. http://www.ncbi.nlm.nih.gov/pubmed/18923068
- Fineberg NA, Saxena S, Zohar J, et al. Obsessive-compulsive disorder: boundary issues. CNS Spectr [Internet]. 2007 May 7;12(5):359–375. https://www.cambridge.org/core/product/identifier/S1092852900021167/type/journal_article
- Stein DJ, Kogan CS, Atmaca M, et al. The classification of obsessive-compulsive and related disorders in the ICD-11. J Affect Disord [Internet]. Jan 15 2016;190:663–674. http://www.ncbi.nlm.nih.gov/pubmed/26590514
- Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the National comorbidity survey replication. Mol Psychiatry [Internet]. 2010 Jan 26;15(1):53–63. https://www.nature.com/articles/mp200894
- Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am [Internet]. 1992 Dec;15(4):743–758. http://www.ncbi.nlm.nih.gov/pubmed/1461792
- Fontenelle LF, Hasler G. The analytical epidemiology of obsessive–compulsive disorder: risk factors and correlates. Prog Neuro Psychopharmacol Biol Psychiatry [Internet]. 2008 Jan;32(1):1–15. https://linkinghub.elsevier.com/retrieve/pii/S0278584607002175
- Rosenberg CM. Complications of obsessional neurosis. Br J Psychiatry [Internet]. 1968 Apr 29;114(509):477–478. https://www.cambridge.org/core/product/identifier/S0007125000099475/type/journal_article
- Goodwin DW. Follow-up studies in obsessional neurosis. Arch Gen Psychiatry [Internet]. 1969 Feb 1;20(2):182. http://archpsyc.jamanetwork.com/articleaspx?
- Meier SM, Mattheisen M, Mors O, et al. Mortality among persons with obsessive-compulsive disorder in Denmark. JAMA Psychiatry [Internet]. 2016 Mar;73(3):268–274. http://www.ncbi.nlm.nih.gov/pubmed/26818216
- Isomura K, Brander G, Chang Z, et al. Metabolic and cardiovascular complications in obsessive-compulsive disorder: a total population, sibling comparison study with long-term follow-up. Biol Psychiatry [Internet]. 2018 Sep;84(5):324–331. https://linkinghub.elsevier.com/retrieve/pii/S0006322317322862
- Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive–compulsive disorder. Prog Neuro Psychopharmacol Biol Psychiatry [Internet]. 2006 May;30(3):327–337. https://linkinghub.elsevier.com/retrieve/pii/S0278584605003465
- Adam Y, Meinlschmidt G, Gloster AT, et al. Obsessive–compulsive disorder in the community: 12-month prevalence, comorbidity and impairment. Soc Psychiatry Psychiatr Epidemiol [Internet]. 2012 Mar 2;47(3):339–349. doi: 10.1007/s00127-010-0337-5
- Fontenelle LF, Mendlowicz MV, Marques C, et al. Trans-cultural aspects of obsessive–compulsive disorder: a description of a Brazilian sample and a systematic review of international clinical studies. J Psychiatr Res [Internet]. 2004 Jul;38(4):403–411. https://linkinghub.elsevier.com/retrieve/pii/S0022395604000020
- Hauschildt M, Jelinek L, Randjbar S, et al. Generic and illness-specific quality of life in obsessive-compulsive disorder. Behav Cogn Psychother [Internet]. 2010 Jul 8;38(4):417–436. https://www.cambridge.org/core/product/identifier/S1352465810000275/type/journal_article
- Eisen JL, Mancebo MA, Pinto A, et al. Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry [Internet]. 2006 Jul;47(4):270–275. https://linkinghub.elsevier.com/retrieve/pii/S0010440X05001513
- Vikas A, Avasthi A, Sharan P. Psychosocial impact of obsessive-compulsive disorder on patients and their caregivers: a comparative study with depressive disorder. Int J Soc Psychiatry [Internet]. 2011 Jan 15;57(1):45–56. doi: 10.1177/0020764009347333
- Torres AR, Ramos-Cerqueira ATA, Ferrão YA, et al. Suicidality in obsessive-compulsive disorder. J Clin Psychiatry [Internet]. 2011 Jan 15;72(1):17–26. http://article.psychiatrist.com/?ContentType=START&ID=10007245
- Torres AR, Prince MJ, Bebbington PE, et al. Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National psychiatric morbidity survey of 2000. Am J Psychiatry [Internet]. 2006 Nov;163(11):1978–1985. doi: 10.1176/ajp.2006.163.11.1978
- Kalra H, Trivedi JK, Dalal PK, et al. Uncomplicated and complicated obsessive-compulsive disorder: an exploratory study from India. Compr Psychiatry [Internet]. 2008 Jan;49(1):51–54. https://linkinghub.elsevier.com/retrieve/pii/S0010440X07001150
- Tükel R, Polat A, Ö Ö, et al. Comorbid conditions in obsessive-compulsive disorder. Compr Psychiatry [Internet]. 2002 May;43(3):204–209. https://linkinghub.elsevier.com/retrieve/pii/S0010440X02293153
- Torres AR, Fontenelle LF, Shavitt RG, et al. Comorbidity variation in patients with obsessive–compulsive disorder according to symptom dimensions: results from a large multicentre clinical sample. J Affect Disord [Internet]. 2016 Jan;190:508–516. https://linkinghub.elsevier.com/retrieve/pii/S0165032715305930
- LaSalle VH, Cromer KR, Nelson KN, et al. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder. Depress Anxiety [Internet]. 2004;19(3):163–173. https://onlinelibrary.wiley.com/doi/10.1002/da.20009
- Miguel EC, Ferrão YA, Do RM, et al. The Brazilian research Consortium on obsessive-compulsive spectrum disorders: recruitment, assessment instruments, methods for the development of multicenter collaborative studies and preliminary results. Rev Bras Psiquiatr [Internet]. 2008 Sep; 30(3):185–196. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462008000300003&lng=en&tlng=en
- Overbeek T, Schruers K, Vermetten E, et al. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry. 2002;63(12):1106–1112. doi: 10.4088/JCP.v63n1204
- Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol [Internet]. 2011 Sep;21(9):655–679. https://linkinghub.elsevier.com/retrieve/pii/S0924977X11001726
- Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet [Internet]. 2012 Dec;380(9859):2224–2260. https://linkinghub.elsevier.com/retrieve/pii/S0140673612617668
- Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States. J Clin Psychiatry [Internet]. 2003 Dec 15;64(12):1465–1475. http://article.psychiatrist.com/?ContentType=START&ID=10000620
- Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication. Arch Gen Psychiatry [Internet]. 2005 Jun 1;62(6):593. http://archpsyc.jamanetwork.com/article.aspx?
- Kessler R. Sex and depression in the National comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J Affect Disord [Internet]. 1993 Nov;29(2–3):85–96. https://linkinghub.elsevier.com/retrieve/pii/016503279390026G
- Zisook S, Lesser I, Stewart JW, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry [Internet]. 2007 Oct;164(10):1539–1546. doi: 10.1176/appi.ajp.2007.06101757
- Bhattacharjee A, Deb S. Suicidal tendencies among depressive patients. J Indian Acad Appl Psychol. 2019 Sep 6;33:213–218.
- Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry [Internet]. 1999;60(Suppl 2):57–62. discussion 75-6, 113R–6. http://www.ncbi.nlm.nih.gov/pubmed/10073389
- Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the medical outcomes study. JAMA [Internet]. 1989 Aug 18;262(7):914–919. http://www.ncbi.nlm.nih.gov/pubmed/2754791
- Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J [Internet]. 2006 Nov 13;27(23):2763–2774. doi: 10.1093/eurheartj/ehl338
- Rugulies R. Depression as a predictor for coronary heart disease. Am J Prev Med [Internet]. 2002 Jul;23(1):51–61. https://linkinghub.elsevier.com/retrieve/pii/S0749379702004397
- Van der Kooy K, van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry [Internet]. 2007 Jul;22(7):613–626. doi: 10.1002/gps.1723
- Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med [Internet]. 2003 Mar;65(2):201–210. http://journals.lww.com/00006842-200303000-00005
- Gan Y, Gong Y, Tong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry [Internet]. 2014 Dec 24;14(1):371. https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-014-0371-z
- Surtees PG, Wainwright NWJ, Luben RN, et al. Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. Am J Psychiatry [Internet]. 2008 Apr;165(4):515–523. doi: 10.1176/appi.ajp.2007.07061018
- Lecrubier Y. Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J Clin Psychiatry [Internet]. 2007;68(Suppl 2):36–41. http://www.ncbi.nlm.nih.gov/pubmed/17288506
- Rost K, Zhang M, Fortney J, et al. Persistently poor outcomes of undetected major depression in primary care. Gen Hosp Psychiatry [Internet]. 1998 Jan;20(1):12–20. https://linkinghub.elsevier.com/retrieve/pii/S0163834397000959
- Ghio L, Gotelli S, Marcenaro M, et al. Duration of untreated illness and outcomes in unipolar depression: a systematic review and meta-analysis. J Affect Disord [Internet]. 2014 Jan;152–154:45–51. https://linkinghub.elsevier.com/retrieve/pii/S0165032713007313
- Hung C-I, Liu C-Y, Yang C-H. Untreated duration predicted the severity of depression at the two-year follow-up point. Hashimoto K, editor. PLoS One [Internet]. 2017 Sep 21;12(9):e0185119. https://dx.plos.org/10.1371/journal.pone.0185119
- Bukh JD, Bock C, Vinberg M, et al. The effect of prolonged duration of untreated depression on antidepressant treatment outcome. J Affect Disord [Internet]. 2013 Feb;145(1):42–48. https://linkinghub.elsevier.com/retrieve/pii/S0165032712005150
- Habert J, Katzman MA, Oluboka OJ, et al. Functional recovery in major depressive disorder. Prim Care Companion CNS Disord [Internet]. 2016Sep 1. http://www.psychiatrist.com/PCC/article/Pages/2016/v18n05/15r01926.aspx
- Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry [Internet]. 2010 Dec 6;67(12):1265. http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archgenpsychiatry.2010.151
- Bolhuis K, Mcadams TA, Monzani B, et al. Aetiological overlap between obsessive-compulsive and depressive symptoms: a longitudinal twin study in adolescents and adults. Psychol Med. 2014;44(7):1439–1449. doi: 10.1017/S0033291713001591
- Tükel R, Meteris H, Koyuncu A, et al. The clinical impact of mood disorder comorbidity on obsessive–compulsive disorder. Eur Arch Psychiatry Clin Neurosci [Internet]. 2006 Jun 12;256(4):240–245. http://link.springer.com/10.1007/s00406-006-0632-z
- Zimmerman M, Mattia JI. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatr Serv. 2000;51(10):1299–1304. doi: 10.1176/appi.ps.51.10.1299
- Newth S, Rachman S. The concealment of obsessions. Behav Res Ther [Internet]. 2001 Apr;39(4):457–464. https://linkinghub.elsevier.com/retrieve/pii/S0005796700000061
- Grant JE, Redden SA, Medeiros GC, et al. Trichotillomania and its clinical relationship to depression and anxiety. Int J Psychiatry Clin Pract [Internet]. 2017 Oct 2;21(4):302–306. doi: 10.1080/13651501.2017.1314509
- Kancherla N, Garlapati SKP, Sowkhya P, et al. A case of coexisting depression and hoarding disorder. Cureus [Internet]. 2022 Jun 3. https://www.cureus.com/articles/99977-a-case-of-coexisting-depression-and-hoarding-disorder
- Quarantini LC, Torres AR, Sampaio AS, et al. Comorbid major depression in obsessive-compulsive disorder patients. Compr Psychiatry [Internet]. 2011;52(4):386–393. doi: 10.1016/j.comppsych.2010.09.006
- Rickelt J, Viechtbauer W, Lieverse R, et al. The relation between depressive and obsessive-compulsive symptoms in obsessive-compulsive disorder: results from a large, naturalistic follow-up study. J Affect Disord. [Internet]. 2016;203:241–247. doi: 10.1016/j.jad.2016.06.009
- Belli GM, Law C, Mancebo M, et al. Directionality of change in obsessive compulsive disorder and depression over six years of prospective follow-up. J Psychiatr Res [Internet]. 2023;157(November 2022):162–167. doi: 10.1016/j.jpsychires.2022.11.034
- Tecuta L, Tomba E, Grandi S, et al. Demoralization: a systematic review on its clinical characterization. Psychol Med. 2015;45(4):673–691. doi: 10.1017/S0033291714001597
- Gittleson NL. The fate of obsessions in depressive psychosis. Br J Psychiatry. 1966;112(488):705–708. doi: 10.1192/bjp.112.488.705
- Gittleson NL. The phenomenology of obsessions in depressive psychosis. Br J Psychiatry. 1966;112(484):261–264. doi: 10.1192/bjp.112.484.261
- Gittleson NL. The effect of obsessions on depressive psychosis. Br J Psychiatry. 1966;112(484):253–259. doi: 10.1192/bjp.112.484.253
- Tibi L, van Oppen P, van Balkom AJLM, et al. The long-term association of OCD and depression and its moderators: a four-year follow up study in a large clinical sample. Eur Psychiatry [Internet]. 2017;44:76–82. doi: 10.1016/j.eurpsy.2017.03.009
- Hellberg SN, Abramowitz JS, Ojalehto HJ, et al. Co-occurring depression and obsessive-compulsive disorder: a dimensional network approach. J Affect Disord [Internet]. 2022;317(August):417–426. doi: 10.1016/j.jad.2022.08.101
- Murphy DL, Moya PR, Fox MA, et al. Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive–compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philos Trans R Soc B Biol Sci. 2013;368(1615):20120435. doi: 10.1098/rstb.2012.0435
- Hoehn-Saric R, Ninan P, Black DW, et al. Multicenter Double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry. 2000 Jan;57(1):76. doi: 10.1001/archpsyc.57.1.76
- Dykshoorn KL. Trauma-related obsessive–compulsive disorder: a review. Health Psychol Behav Med Internet. 2014/01/01 2014 Jan 23;2(1):517–528. https://www.tandfonline.com/doi/full/10.1080/21642850.2014.905207
- Ding Y, Dai J. Advance in stress for depressive disorder. 2019;147–178. https://link.springer.com/10.1007/978-981-32-9271-0_8
- Orozco A, Cardoner N, Aragón CF, et al. Obsessive–compulsive symptoms in anxiety and depressive disorders: influence of recent and/or traumatic life events. Revista de Psiquiatría y Salud Mental [Internet]. 2021;14(4):218–226. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099339933&doi=10.1016%2Fj.rpsm.2020.12.002&partnerID=40&md5=f13e8ef7a658c2ff9f3759417e506f0a
- Baxter LR. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry [Internet]. 1987 Mar 1;44(3):211. doi: 10.1001/archpsyc.1987.01800150017003
- Baxter LR. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry [Internet]. 1992 Sep 1;49(9):681. 10.1001/archpsyc.1992.01820090009002
- Saxena S, Brody AL, Ho ML, et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry. 2001;50(3):159–170. doi: 10.1016/S0006-3223(01)01123-4
- Frost RO, Steketee G. Cognitive approaches to obsessions and compulsions: theory, assessment, and treatment. 1st ed. Frost RO, Steketee G, editors. Pergamon; 2002. doi: 10.1016/B978-008043410-0/50001-5
- Goodman W, Rudorfer M, Maser JD. Obsessive-compulsive disorder: contemporary issues in treatment. 1st ed. Goodman W, Rudorfer M, Maser JD, editors. Routledge; 1999. doi: 10.4324/9781410603241
- Paterson JL, Reynolds AC, Ferguson SA, et al. Sleep and obsessive-compulsive disorder (OCD). Sleep Med Rev [Internet]. 2013;17(6):465–474. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887606931&doi=10.1016%2Fj.smrv.2012.12.002&partnerID=40&md5=e2282b8fd0292ba228316e38fafb469c
- Jansson-Fröjmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res [Internet]. 2008 Apr;64(4):443–449. https://linkinghub.elsevier.com/retrieve/pii/S0022399907004114
- Díaz-Román A, Perestelo-Pérez L, Buela-Casal G. Sleep in obsessive-compulsive disorder: a systematic review and meta-analysis. Sleep Med [Internet]. 2015;16(9):1049–1055. doi: 10.1016/j.sleep.2015.03.020
- Steiger A, Pawlowski M. Depression and sleep. Int J Mol Sci [Internet]. 2019 Jan 31;20(3):607. doi: 10.3390/ijms20030607
- Nota JA, Sharkey KM, Coles ME. Sleep, arousal, and circadian rhythms in adults with obsessive-compulsive disorder: a meta-analysis. Neurosci Biobehav Rev [Internet]. 2015;51:100–107. doi: 10.1016/j.neubiorev.2015.01.002.
- Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron [Internet]. 2020 Jul;107(2):234–256. https://linkinghub.elsevier.com/retrieve/pii/S0896627320304311
- Marazziti D, Mucci F, Fontenelle LF. Immune system and obsessive-compulsive disorder. Psychoneuroendocrinology [Internet]. 2018 Jul;93:39–44. https://linkinghub.elsevier.com/retrieve/pii/S0306453018302841
- Bulut NS, Yorguner N, Çarkaxhiu Bulut G. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil–lymphocyte and platelet–lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder. Nord J Psychiatry [Internet]. 2021;75(8):624–632. doi: 10.1080/08039488.2021.1919201
- Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr [Internet]. 2018 Feb 23;30(1):1–16. https://www.cambridge.org/core/product/identifier/S0924270816000697/type/journal_article
- Suneson K, Lindahl J, Chamli Hårsmar S, et al. Inflammatory depression—mechanisms and non-pharmacological interventions. Int J Mol Sci [Internet]. 2021 Feb 6;22(4):1640. doi: 10.3390/ijms22041640
- van den Heuvel LL, Suliman S, Bröcker E, et al. The association between hair cortisol levels, inflammation and cognitive functioning in females. Psychoneuroendocrinology [Internet]. 2022 Feb;136:105619. https://linkinghub.elsevier.com/retrieve/pii/S0306453021004935
- Jia Y, Liu L, Sheng C, et al. Increased Serum levels of cortisol and inflammatory cytokines in people with depression. J Nerv Ment Dis [Internet]. 2019 Apr;207(4):271–276. https://journals.lww.com/00005053-201904000-00008
- Labad J, Soria V, Salvat-Pujol N, et al. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression. Psychoneuroendocrinology [Internet]. 2018;93(June 2017):20–28. doi: 10.1016/j.psyneuen.2018.04.008
- Lee DY, Kim E, Choi MH. Technical and clinical aspects of cortisol as a biochemical marker of chronic stress. BMB Rep [Internet]. 2015 Apr 30;48(4):209–216. doi: 10.5483/BMBRep.2015.48.4.275
- Zorn JV, Schür RR, Boks MP, et al. Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis. Psychoneuroendocrinology [Internet]. 2017 Mar;77:25–36. https://linkinghub.elsevier.com/retrieve/pii/S0306453016304735
- Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuro Psychopharmacol Biol Psychiatry [Internet]. 2006 May;30(3):400–412. https://linkinghub.elsevier.com/retrieve/pii/S0278584605003520
- Kennedy SH, Lam RW, McIntyre RS, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder. Can J Psychiatry. 2016 Sep;61(9):540–560. doi: 10.1177/0706743716659417
- NICE. Depression in adults: treatment and management. 2022.
- Pizarro M, Fontenelle LF, Paravidino DC, et al. An updated review of antidepressants with marked serotonergic effects in obsessive–compulsive disorder. Expert Opin Pharmacother. 2014 Jul 3;15(10):1391–1401. InternetAvailable from. doi: 10.1517/14656566.2014.914493
- Rector NA, Cassin SE, Richter MA. Psychological treatment of obsessive-compulsive disorder in patients with major depression: a pilot randomized controlled trial. Can J Psychiatry InternetAvailable from. 2009 Dec 1;54(12):846–851. doi: 10.1177/070674370905401208
- de Oliveira MVS, de Barros PMF, de Mathis MA, et al. Brazilian psychiatric association guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment. Brazilian J Psychiatry. 2023. doi: 10.47626/1516-4446-2022-2891
- Zohar J, Zohar-Kadouch RC, Kindler S. Current concepts in the pharmacological treatment of obsessive-compulsive disorder. Drugs. 1992 Feb;43(2):210–218. doi: 10.2165/00003495-199243020-00007
- den Boer JA. Psychopharmacology of comorbid obsessive-compulsive disorder and depression. J Clin Psychiatry. 1997;58(suppl 8):17–19.
- Peters MD, Davis SK, Austin LS. Clomipramine: an antiobsessional tricyclic antidepressant. Clin Pharm. 1990 Mar;9(3):165–178. InternetAvailable from: http://www.ncbi.nlm.nih.gov/pubmed/2180623
- Katz RJ, DeVeaugh-Geiss J. The antiobsessional effects of clomipramine do not require concomitant affective disorder. Psychiatry Res. 1990 Feb;31(2):121–129. doi: 10.1016/0165-1781(90)90115-L
- Ruberto VL, Jha MK, Murrough JW. Pharmacological treatments for patients with treatment-resistant depression. Pharmaceuticals. 2020 Jun 4;13(6):116. InternetAvailable from. doi: 10.3390/ph13060116
- Fineberg NA, Van Ameringen M, Drummond L, et al. How to manage obsessive-compulsive disorder (OCD) under COVID-19: a clinician’s guide from the International College of obsessive compulsive Spectrum disorders (ICOCS) and the obsessive-compulsive and related disorders research network (OCRN) of the Europ. Compr Psychiatry. 2020 Jul;100:152174. InternetAvailable from: https://linkinghub.elsevier.com/retrieve/pii/S0010440X2030016X
- Berman NC, Hezel DM, Wilhelm S. Is my patient too sad to approach their fear? Depression severity and imaginal exposure outcomes for patients with OCD. J Behav Ther Exp Psychiatry. InternetAvailable from2021Mar70101615https://linkinghub.elsevier.com/retrieve/pii/S0005791619301958
- Motivala SJ, Arellano M, Greco RL, et al. Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy. Int J Psychiatry Clin Pract. 2018 Jan 2;22(1):40–46. InternetAvailable from. doi: 10.1080/13651501.2017.1351991
- Steketee G, Chambless DL, Tran GQ. Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Compr Psychiatry. 2001;42(1):76–86. doi: 10.1053/comp.2001.19746
- Abramowitz JS, Foa EB. Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD? Behav Ther. 2000;31(4):795–800. doi: 10.1016/S0005-7894(00)80045-3
- Jacoby RJ, Abramowitz JS. Treatment of comorbid depression and obsessive-compulsive disorder. In: Clinical handbook of obsessive-compulsive and related disorders [internet]. Cham: Springer International Publishing; 2016. p. 371–383. Available from. doi: 10.1007/978-3-319-17139-5_25
- Başoǧlu M, Lax T, Kasvikis Y, et al. Predictors of improvement in obsessive-compulsive disorder. J Anxiety Disord. 1988;2(4):299–317. doi: 10.1016/0887-6185(88)90026-6
- Storch EA, Lewin AB, Farrell L, et al. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities? J Anxiety Disord. 2010;24(6):547–552. InternetAvailable from. doi: 10.1016/j.janxdis.2010.03.013
- McKay D, Sookman D, Neziroglu F, et al. Efficacy of cognitive-behavioral therapy for obsessive–compulsive disorder. Psychiatry Res. 2015 Feb;225(3):236–246. InternetAvailable from: https://linkinghub.elsevier.com/retrieve/pii/S0165178114009512
- Wheaton MG, Gallina ER. Using cognitive-behavioral therapy to treat obsessive-compulsive disorder with co-occurring depression. J Cogn Psychother [Internet]. 2019 Aug 1;33(3):228–241. Available from. 10.1891/0889-8391.33.3.228
- Zandberg LJ, Zang Y, McLean CP, et al.Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention. Behav Res Ther [Internet] 2015 May; 68:76–81. https://linkinghub.elsevier.com/retrieve/pii/S0005796715000443
- Operant therapy for excessive checking. Vol. 3. University of Toronto Press; 1971. p. 194–197.
- Albert U, Di Salvo G, Solia F, et al. Combining drug and psychological treatments for obsessive- compulsive disorder: what is the evidence, when and for whom. Curr Med Chem. 2019 Jan 31;25(41):5632–5646. InternetAvailable from: https://www.eurekaselect.com/154163/article
- Bluett EJ, Homan KJ, Morrison KL, et al. Acceptance and commitment therapy for anxiety and OCD spectrum disorders: an empirical review. J Anxiety Disord. 2014 Aug;28(6):612–624. InternetAvailable from: https://linkinghub.elsevier.com/retrieve/pii/S0887618514000917
- Twohig MP, Levin ME. Acceptance and commitment therapy as a treatment for anxiety and depression. Psychiatr Clin North Am. 2017 Dec;40(4):751–770. InternetAvailable from: https://linkinghub.elsevier.com/retrieve/pii/S0193953X17300771
- Thiel N, Jacob GA, Tuschen-Caffier B, et al. Schema therapy augmented exposure and response prevention in patients with obsessive–compulsive disorder: feasibility and efficacy of a pilot study. J Behav Ther Exp Psychiatry. 2016 Sep;52:59–67. InternetAvailable from: https://linkinghub.elsevier.com/retrieve/pii/S0005791616300234
- Marsden Z, Lovell K, Blore D, et al. A randomized controlled trial comparing EMDR and CBT for obsessive-compulsive disorder. Clin Psychol Psychother. 2018 Jan;25(1):e10–8. InternetAvailable from. doi: 10.1002/cpp.2120
- Carletto S, Malandrone F, Berchialla P, et al. Eye movement desensitization and reprocessing for depression: a systematic review and meta-analysis. Eur J Psychotraumatol. 2021 Jan 1;12(1). InternetAvailable from. 10.1080/20008198.2021.1894736
- Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes. JAMA Psychiatry. 2017 Feb;74(2):143. doi: 10.1001/jamapsychiatry.2016.3644
- Mutz J, Vipulananthan V, Carter B, et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ. 2019 Mar;l1079. doi: 10.1136/bmj.l1079
- Brunoni AR, Sampaio-Junior B, Moffa AH, et al. Noninvasive brain stimulation in psychiatric disorders: a primer. Rev Bras Psiquiatr. 2019;41(1):70–81. doi: 10.1590/1516-4446-2017-0018
- Liang K, Li H, Bu X, et al. Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Transl Psychiatry. 2021 May;11(1):332. doi: 10.1038/s41398-021-01453-0
- Trevizol AP, Shiozawa P, Cook IA, et al. Transcranial magnetic stimulation for obsessive-compulsive disorder. J ECT. 2016 Dec;32(4):262–266. doi: 10.1097/YCT.0000000000000335
- Carmi L, Tendler A, Bystritsky A, et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized Double-blind placebo-controlled trial. Am J Psychiatry. 2019 Nov;176(11):931–938. doi: 10.1176/appi.ajp.2019.18101180
- Naafs MA. FDA approvals of medical devices under the De novo automatic class 3 regulations: an opinion. Biomed J Sci Tech Res. 2018 Aug;8(2). doi: 10.26717/BJSTR.2018.08.001623
- Pellegrini L, Garg K, Enara A, et al. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: a meta-analysis and clinical implications. Compr Psychiatry. 2022 Oct;118:152339.
- Roth Y, Tendler A, Arikan MK, et al. Real-world efficacy of deep TMS for obsessive-compulsive disorder: post-marketing data collected from twenty-two clinical sites. J Psychiatr Res. 2021 May;137:667–672.
- Thatikonda NS, Vinod P, Balachander S, et al. Efficacy of repetitive transcranial magnetic stimulation on comorbid anxiety and depression symptoms in obsessive-compulsive disorder: a meta-analysis of randomized sham-controlled trials. Can J Psychiatry Internet. 2023 Jun 22;68(6):407–417. http://journals.sagepub.com/doi/10.1177/07067437221121112
- Trifu S, Sevcenco A, Stănescu M, et al. Efficacy of electroconvulsive therapy as a potential first‑choice treatment in treatment‑resistant depression (review). Exp Ther Med. 2021 Sep 9;22(5):1281. InternetAvailable from. doi: 10.3892/etm.2021.10716
- Bais M, Figee M, Denys D. Neuromodulation in obsessive-compulsive disorder. Psychiatr Clin North Am [Internet]. 2014;37(3):393–413. doi: 10.1016/j.psc.2014.06.003
- Chiu C-H, Yang W-C, Lin C-H. Electroconvulsive therapy in treatment-resistant obsessive-compulsive disorder comorbid with major depressive disorder. J ECT InternetAvailable from. 2020 Sep;36(3):e34–5. https://journals.lww.com/10.1097/YCT.0000000000000660
- Liu X, Cui H, Wei Q, et al. Electroconvulsive therapy on severe obsessive-compulsive disorder comorbid depressive symptoms. Psychiatry Investigation [Internet]. 2014;11(2):210. doi: 10.4306/pi.2014.11.2.210
- Fontenelle LF, Coutinho ESF, Lins-Martins NM, et al. Electroconvulsive therapy for obsessive-compulsive disorder. J Clin Psychiatry [Internet]. 2015 Jul 22;76(7):949–957. http://www.psychiatrist.com/jcp/article/pages/2015/v76n07/v76n0724.aspx
- Shah DB, Pesiridou A, Baltuch GH, et al. Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont) [Internet]. 2008;5(9):24–33. http://www.ncbi.nlm.nih.gov/pubmed/19727257%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2687086
- Neumann W-J, Huebl J, Brücke C, et al. Different patterns of local field potentials from limbic DBS targets in patients with major depressive and obsessive compulsive disorder. Mol Psychiatry [Internet]. 2014 Nov 11;19(11):1186–1192. https://www.nature.com/articles/mp20142
- Youssef NA, Phung P, Patel RS. Characteristics of patients who received deep brain stimulation in obsessive-compulsive disorder versus major depressive disorder. J Psychiatr Res [Internet]. 2021 Apr;136:384–387. https://linkinghub.elsevier.com/retrieve/pii/S0022395621000996
- Sullivan CRP, Olsen S, Widge AS. Deep brain stimulation for psychiatric disorders: from focal brain targets to cognitive networks. Neuroimage [Internet]. 2021 Jan;225:117515. https://linkinghub.elsevier.com/retrieve/pii/S1053811920310004
- Tyagi H, Apergis-Schoute AM, Akram H, et al. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: clinical and imaging evidence for dissociable effects. Biol Psychiatry [Internet]. 2019 May;85(9):726–734. https://linkinghub.elsevier.com/retrieve/pii/S0006322319300630
- Jelen LA, Stone JM. Ketamine for depression. Int Rev Psychiatry. 2021 Apr 3;33(3):207–228. InternetAvailable from. doi: 10.1080/09540261.2020.1854194
- Matteo M, Cristian P, Laura M, et al. The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report. Ann Gen Psychiatry [Internet]. 2021 Dec 16;20(1):43. https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-021-00365-z
- Bandeira ID, Lins-Silva DH, Cavenaghi VB, et al. Ketamine in the treatment of obsessive-compulsive disorder: a systematic review. Harv Rev Psychiatry [Internet]. 2022 Mar;30(2):135–145. doi: 10.1097/HRP.0000000000000330
- Rodriguez CI, Kegeles LS, Levinson A, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013 Nov 19;38(12):2475–2483. InternetAvailable from: https://www.nature.com/articles/npp2013150
- Dalgleish T, Black M, Johnston D, et al. Transdiagnostic approaches to mental health problems: Current status and future directions. J Consult Clin Psychol [Internet]. 2020 Mar;88(3):179–195. doi: 10.1037/ccp0000482
- Marx W, Manger SH, Blencowe M, et al. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of lifestyle Medicine (ASLM) taskforce. World J Biol Psychiatry [Internet]. 2022 Oct 6:1–54. https://www.tandfonline.com/doi/full/10.1080/15622975.2022.2112074
- Brierley M-E, Albertella L, Christensen E, et al. Lifestyle risk factors for obsessive-compulsive symptoms and related phenomena: what should lifestyle interventions target? Aust N Z J Psychiatry [Internet]. 2023 Mar 1;57(3):379–390. doi: 10.1177/00048674221085923
- Brierley M-E, Thompson EM, Albertella L, et al. Lifestyle interventions in the treatment of obsessive-compulsive and related disorders: a systematic review. Psychosom Med [Internet]. 2021 Oct;83(8):817–833. doi: 10.1097/PSY.0000000000000988
- Moret C, Isaac M, Briley M. Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors. J Psychopharmacol [Internet]. 2009 Nov 17;23(8):967–974. doi: 10.1177/0269881108093582
- Shofty B, Gadot R, Provenza N, et al. Neurosurgical approaches for treatment-resistant obsessive-compulsive disorder. Psychiatr Clin North Am [Internet]. 2023 Mar;46(1):121–132. https://linkinghub.elsevier.com/retrieve/pii/S0193953X22000995
- Kellner CH, Greenberg RM, Murrough JW, et al. ECT in treatment-resistant depression. Am J Psychiatry [Internet]. 2012 Dec;169(12):1238–1244. doi: 10.1176/appi.ajp.2012.12050648
- Hoskins MD, Bridges J, Sinnerton R, et al. Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches. Eur J Psychotraumatol [Internet]. 2021 Jan 1;12(1). 10.1080/20008198.2020.1802920
- Chawla N, Anothaisintawee T, Charoenrungrueangchai K, et al. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. BMJ [Internet]. 2022 Jan 19:e066084. doi: 10.1136/bmj-2021-066084
- de Menezes GB, Coutinho ESF, Fontenelle LF, et al. Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Psychopharmacol (Berl) [Internet]. 2011 May 22;215(1):1–11. doi: 10.1007/s00213-010-2113-3
- Slee A, Nazareth I, Freemantle N, et al. Trends in generalised anxiety disorders and symptoms in primary care: UK population-based cohort study. Br J Psychiatry [Internet]. 2021 Mar 8;218(3):158–164. https://www.cambridge.org/core/product/identifier/S0007125020001592/type/journal_article